The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions

The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions

Epidermal Growth Factor Receptor inhibitors (EGFRi) are approved as therapeutic options in several solid tumors. Cutaneous papulopustular eruption is the most frequent cutaneous adverse-event (AE), usually treated with emollient or corticosteroids according to toxicity grade. Our study evaluated the...

Full description

Bibliographic Details
Main Authors: Mauro Bavetta, Dionisio Silvaggio, Elena Campione, Pietro Sollena, Vincenzo Formica, Deborah Coletta, Grazia Graziani, Maria Concetta Pucci Romano, Mario Roselli, Ketty Peris, Luca Bianchi
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Journal of Clinical Medicine
Subjects:
EGFR inhibitors
polydatin
papulopustular rash
cutaneous adverse events
Online Access:https://www.mdpi.com/2077-0383/10/3/466

Internet

https://www.mdpi.com/2077-0383/10/3/466

Similar Items